Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medica SurB de CVMSURF 81 3-1 Month Momentum % is N/A% as of Aug. 07, 2026. GuruFocus rates MSURF with a GF Score™ of 81/100 and a GF Value™ of $0.53. The stock has 5 warning signs investors should review. Among 674 Healthcare Providers & Services companies, Medica SurB de CV ranks better than 54.15% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-07), Medica SurB de CV's 3-1 Month Momentum % is N/A%.
The industry rank for Medica SurB de CV's 3-1 Month Momentum % or its related term are showing as below:
MSURF's 3-1 Month Momentum % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: -2.265 * Ranked among companies with meaningful 3-1 Month Momentum % only.
Medica SurB de CV (OTCPK:MSURF) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Medica SurB de CV 3-1 Month Momentum % Related Terms
MSURF vs HCA, THC, DVA: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Medica SurB de CV's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medica SurB de CV 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medica SurB de CV's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Medica SurB de CV's 3-1 Month Momentum % falls into.
Medica SurB de CV (OTCPK:MSURF) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medica SurB de CV (MSURF) has a 3-1 Month Momentum % of N/A% as of Aug. 07, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Medica SurB de CV and its competitors. According to the industry distribution chart, Medica SurB de CV ranks #309 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 45.8%.
Is Medica SurB de CV's 3-1 Month Momentum % too high?
Medica SurB de CV's current 3-1 Month Momentum % is N/A%. Based on the distribution chart, Medica SurB de CV ranks #309 out of 674 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medica SurB de CV has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Medica SurB de CV's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medica SurB de CV ranks #309 out of 674 companies for 3-1 Month Momentum %. This puts Medica SurB de CV in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Medica SurB de CV and its competitors. Medica SurB de CV's current 3-1 Month Momentum % is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medica SurB de CV stock overvalued right now?
Medica SurB de CV (MSURF) has a current 3-1 Month Momentum % of N/A%. The stock's GF Value™ is $0.53, compared to a current price of $0.67 — trading 27% above its estimated fair value. The current 3-1 Month Momentum % is N/A%. Medica SurB de CV's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Medica SurB de CV (MSURF), the current 3-1 Month Momentum % is N/A% as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medica SurB de CV (MSURF) Overvalued in 2026?
Based on GuruFocus' analysis, Medica SurB de CV stock appears to be overvalued.
The current stock price of $0.67 is trading 27% above its estimated GF Value™ of $0.53.
Key valuation signals for MSURF:
3-1 Month Momentum %: N/A%
GF Value™: $0.53 vs. price of $0.67 (27% above fair value)
No single metric tells the full story. See the MSURF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medica Sur SAB de CV is a medical care company specializes in emergency scenarios. The company offers emergency ambulance transportation, air transportation and paramedic assistance.
81GF Score
Get the complete analysis for MSURF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSURF has been successfully added to your 
